'Scout scans' map the way in non-Hodgkin's lymphoma treatment
Monday, June 7, 2010 - 12:31
in Health & Medicine
According to a study presented at SNM's 57th Annual Meeting, molecular imaging can evaluate and optimize non-Hodgkin's lymphoma therapy with Zevalin, a front-line radioimmunotherapy drug that uses a dose of radioactive material and mimics the body's own immune response to target and kill cancer cells while sparing nearby healthy tissues.